B.G. Campling, L.C. Young, K.A. Baer, Y-M Lam, R.G. Deeley, S.P.C. Cole and J.H. Gerlach. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer. Clin. Cancer Res. 3: 115-122 (1997).
R.G. Deeley and S.P.C. Cole. Multidrug resistance in mammalian cells mediated by members of the ATP-binding cassette superfamily: The P-glycoproteins and MRP. In, Molecular Genetics of Drug Resistance, Modern Genetics, Vol. 3, (eds. J.D. Hayes and C.R. Wolf), Chapter 7, pp. 247-298, Harwood Academic, Langhorne, PA. (1997). (invited)
S.E.L. Mirski and S.P.C. Cole. Multidrug resistance in small cell lung cancer. In, Drug Resistance in Oncology (ed. S.D. Bernal), Chapter 2, pp. 27-75, Marcel Dekker, New York. (1997). (invited)
M. Nakagawa, A. Emoto, N. Nasu, T. Hanada, M. Kuwano, S.P.C. Cole and Y. Nomura. Clinical significance of multi-drug resistant associated protein and P-glycoprotein in patients with bladder cancer. J. Urol. 157: 1260-1265 (1997).
B.G. Campling, K.A. Baer, J.H. Gerlach, Y-M. Lam, S.P.C. Cole and S.E.L. Mirski. Topoisomerase II levels and drug response in small cell lung cancer. Biochemistry 36: 5868-5877 (1997).
D.W. Loe, R.K. Stewart, T.E. Massey, R.G. Deeley and S.P.C. Cole. ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the MRP gene. Mol. Pharmacol. 51: 1034-1041 (1997).
H.S.L. Chan, Y. Lu, T.M. Grogan, G. Haddad, D.R. Hipfner, S.P.C. Cole, R.G. Deeley, V. Ling and B.L. Gallie. Multidrug resistance protein (MRP) expression in retinoblastoma correlates with the rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein. Cancer Res. 57: 2325-2330 (1997).
D.R. Hipfner, K.C. Almquist, E.M. Leslie, J.H. Gerlach, C.E. Grant, R.G. Deeley and S.P.C. Cole. Membrane topology of the multidrug resistance protein, MRP: A study of glycosylation-site mutants reveals an extracytosolic NH2-terminus. J. Biol. Chem. 272: 23623-23630 (1997).
B.D. Stride, C.E. Grant, D.W. Loe, D.R. Hipfner, S.P.C. Cole and R.G. Deeley. Pharmacological characterization of the murine and human orthologs of multidrug resistance protein in transfected human embryonic kidney cells. Mol. Pharmacol. 52: 344-353 (1997).
I. Wessel, P.B. Jensen, J. Falck, S.E.L. Mirski, S.P.C. Cole and M. Sehested. Loss of amino acids 1490lys-ser-lys1492 in the COOH-terminal region of topoisomerase II in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization. Cancer Res. 57: 4451-4454 (1997).
C.E. Grant, E.U. Kurz, S.P.C. Cole and R.G. Deeley. Analysis of the intron-exon organization of the human multidrug resistance protein gene (MRP) and alternative splicing of its mRNA. Genomics 45: 368-378 (1997).
S.E.L. Mirski, J.H. Gerlach, H.J. Cummings, R. Zirngibl, P.A. Greer and S.P.C. Cole. Bipartite nuclear localization signals in the C-terminus of human topoisomerase II. Exp. Cell Res. 237: 452-455 (1997).
M.D. Norris, S.B. Bordow, P.S. Haber, G.M. Marshall, M. Kavallaris, J. Madafiglio, S.L. Cohn, H. Salwen, M.L. Schmidt, D.R. Hipfner, S.P.C. Cole, R.G. Deeley and M. Haber. Evidence that the N-myc oncogene regulates MRP gene expression in neuroblastoma. Eur. J. Cancer 33: 1911-1916 (1997).
H.S.L. Chan, T.M. Grogan, G. Haddad, D.R. Hipfner, R.G. Deeley and S.P.C. Cole. Standardization of a single-cell assay for sensitive detection of Multidrug Resistance Protein (MRP) expression in normal and malignant cells in archival clinical samples. J. Lab. Clin. Med. 130: 297-306 (1997).